SCHEMBL21499679

SCHEMBL21499679

CC(C)Sc1nc2c(c(=O)n(CCCOPI)c(=O)n2C)n1Cc1ccc(Cl)cc1

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 6/20 0.68
▸ TSHR P16473 6/20 0.68
▸ MAPT P10636 4/20 0.68
▸ MAPK1 P28482 2/20 0.68
▸ NPSR1 Q6W5P4 2/20 0.68
▸ MEN1 O00255 3/20 0.56
▸ KMT2A Q03164 3/20 0.56
▸ HPGD P15428 2/20 0.56
▸ TP53 P04637 1/20 0.49
▸ XBP1 P17861 1/20 0.49
▸ HTT P42858 1/20 0.48
▸ GAA P10253 1/20 0.47
▸ HSD17B10 Q99714 1/20 0.47
▸ KCNH2 Q12809 1/20 0.46
▸ TRPC4 Q9UBN4 1/20 0.46
▸ TRPC5 Q9UL62 1/20 0.46
▸ CXCL8 P10145 1/20 0.46
▸ NOD2 Q9HC29 1/20 0.46
▸ NOD1 Q9Y239 1/20 0.46
▸ LMNA P02545 2/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19505260 0.90 TSHR (0.53) ALDH1A1TSHRMAPTMAPK1NPSR1
SCHEMBL19505568 0.88 TSHR (0.67) ALDH1A1TSHRMAPTMAPK1NPSR1
SCHEMBL16076237 0.86 ALDH1A1 (0.77) ALDH1A1TSHRMAPTMAPK1NPSR1
SCHEMBL19505591 0.85 ALDH1A1 (0.76) ALDH1A1TSHRMAPTMAPK1NPSR1
SCHEMBL19505419 0.84 TRPC4 (0.49) ALDH1A1TSHRMAPTMAPK1NPSR1
SCHEMBL19505592 0.84 TRPC4 (0.49) ALDH1A1TSHRMAPTMAPK1NPSR1
SCHEMBL19505263 0.82 SMN1; SMN2 (0.50) ALDH1A1TSHRMAPTMAPK1NPSR1
SCHEMBL19505245 0.81 TRPC5 (0.57) ALDH1A1TSHRMAPTMAPK1NPSR1
SCHEMBL19505229 0.81 ATM (0.50) ALDH1A1TSHRMAPTMAPK1NPSR1
SCHEMBL19505286 0.81 ATM (0.46) ALDH1A1TSHRMAPTMAPK1NPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230040259-A1 SUBSTITUTED XANTHINES AND METHODS OF USE THEREOF HYDRA BIOSCIENCES, LLC (US) 2023-02-09 — — US disclosed
US-11208409-B2 Substituted xanthines and methods of use thereof HYDRA BIOSCIENCES, LLC (US) 2021-12-28 — — US disclosed
US-20190322667-A1 SUBSTITUTED XANTHINES AND METHODS OF USE THEREOF BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2019-10-24 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230040259-A1 SUBSTITUTED XANTHINES AND METHODS OF USE THEREOF TRPC5, TRPC7, TRPC4 ALDH1A1 1647/4885TSHR 4540/4885MAPT 2951/4885
US-11208409-B2 Substituted xanthines and methods of use thereof TRPC5, TRPC7, TRPC4 ALDH1A1 1647/4885TSHR 4540/4885MAPT 2951/4885
US-20190322667-A1 SUBSTITUTED XANTHINES AND METHODS OF USE THEREOF TRPC5, TRPC7, TRPC4 ALDH1A1 1647/4885TSHR 4540/4885MAPT 2951/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback